- Tissue Contact Probe Ablators
- Epidermal and Subcutaneous Cryoablation Systems
- Tissue Spray Probe Ablators
Tumour Ablation Devices Market size was valued at USD 1,114.2 million in 2022 and is poised to grow at a CAGR of 10.8% from 2023 to 2029. The report provides a detailed overview of the market, and that can be segmented by Product Type, by Application, by End User. By product type, the global tumour ablation devices market has been segmented into Tissue Contact Probe Ablators, Epidermal and Subcutaneous Cryoablation Systems, Tissue Spray Probe Ablators. The Tissue Contact Probe Ablators Tumour ablation devices segment is likely to be the largest and fastest-growing segment in terms of product type. Based on application, the global tumour ablation devices market is segmented into Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Renal Cancer, Others. Among these, the breast cancer segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on end user, the global market is segmented into Hospitals, Specialty Clinics, and Ambulatory Surgical Centers. The hospitals segment accounts for the largest share in 2021. Specialty clinics segment is the second-largest share during the forecast period 2022-2028.
Tumour Ablation Devices Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
10.8%
Largest Market
North American
Fastest Growing Market
Asia-Pacific
Tumour Ablation Devices Market Dynamics
The development of ablation technology and the trend for minimally invasive procedures are anticipated to propel the market growth over the forecast years. Additionally, it is anticipated that the rise in cancer prevalence and Sedentary lifestyles and the growing senior population around the world are expected to fuel market expansion.
North America Got Significant Share
Tumour Ablation Devices Market Regional Analysis
North America is expected to witness the highest market share during the forecast period due to more government funding for high-quality healthcare in this region. Additionally, the market's growth rate in this region will be boosted by an increase in parity's purchasing power.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The Tumour ablation devices market provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
- The Tumour ablation devices market covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The Tumour ablation devices market outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The Tumour ablation devices market tracks recent innovations, key developments, and start-up details that are actively working in the market
- The Tumour ablation devices market provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Tumour Ablation Devices Market Segmentation
By Product Type
By Application
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Renal Cancer
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The global tumour ablation devices market size is valued at USD 1,387.9 million in 2021 and is expected to grow at a prominent growth rate during the forecast period 2022 to 2028.
The adverse consequences of ablation therapy, including liver infection, abdominal pain, bleeding into the abdomen or chest cavity, and others, may restrict the market growth.
The key players in the market are Boston Scientific Corporation, Cooper Surgical, Sanarus Technologies, Atricure, Inc., IceCure Medical, CPSI Biotech, HealthTronics, Inc., RA Distribution, Brymill Cryogenic Systems, Erbe Elektromedizin, GmbH
| 1. Executive Summary |
| 2. Global Tumour Ablation Devices Market Introduction |
| 2.1. Global Tumour Ablation Devices Market Taxonomy |
| 2.2. Global Tumour Ablation Devices Market Definitions |
| 2.2.1. Product Type |
| 2.2.2. Application |
| 2.2.3. End User |
| 3. Global Tumour Ablation Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Tumour Ablation Devices Market Dynamic Factors - Impact Analysis |
| 3.6. Global Tumour Ablation Devices Market Competition Landscape |
| 3.7. Epidemiology |
| 4. Global Tumour Ablation Devices Market Analysis, 2018 - 2022 and Forecast, 2023- 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Tumour Ablation Devices Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Tissue Contact Probe Ablators |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Epidermal and Subcutaneous Cryoablation Systems |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Tissue Spray Probe Ablators |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Tumour Ablation Devices Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029 |
| 6.1. Breast Cancer |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Prostate Cancer |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Lung Cancer |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Liver Cancer |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Renal Cancer |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Others |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7. Global Tumour Ablation Devices Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Specialty Clinics |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Tumour Ablation Devices Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Tumour Ablation Devices Market - Opportunity Analysis Index, By Product Type, Application, End User, and Region, 2023 - 2029 |
| 9. North America Tumour Ablation Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Tissue Contact Probe Ablators |
| 9.1.2. Epidermal and Subcutaneous Cryoablation Systems |
| 9.1.3. Tissue Spray Probe Ablators |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Breast Cancer |
| 9.2.2. Prostate Cancer |
| 9.2.3. Lung Cancer |
| 9.2.4. Liver Cancer |
| 9.2.5. Renal Cancer |
| 9.2.6. Others |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Hospitals |
| 9.3.2. Specialty Clinics |
| 9.3.3. Ambulatory Surgical Centers |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Tumour Ablation Devices Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2023 - 2029 |
| 9.6. North America Tumour Ablation Devices Market Dynamics Trends |
| 10. Europe Tumour Ablation Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Tissue Contact Probe Ablators |
| 10.1.2. Epidermal and Subcutaneous Cryoablation Systems |
| 10.1.3. Tissue Spray Probe Ablators |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Breast Cancer |
| 10.2.2. Prostate Cancer |
| 10.2.3. Lung Cancer |
| 10.2.4. Liver Cancer |
| 10.2.5. Renal Cancer |
| 10.2.6. Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Hospitals |
| 10.3.2. Specialty Clinics |
| 10.3.3. Ambulatory Surgical Centers |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Tumour Ablation Devices Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2023 - 2029 |
| 10.6. Europe Tumour Ablation Devices Market Dynamics Trends |
| 11. Asia-Pacific Tumour Ablation Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Tissue Contact Probe Ablators |
| 11.1.2. Epidermal and Subcutaneous Cryoablation Systems |
| 11.1.3. Tissue Spray Probe Ablators |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Breast Cancer |
| 11.2.2. Prostate Cancer |
| 11.2.3. Lung Cancer |
| 11.2.4. Liver Cancer |
| 11.2.5. Renal Cancer |
| 11.2.6. Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Hospitals |
| 11.3.2. Specialty Clinics |
| 11.3.3. Ambulatory Surgical Centers |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Tumour Ablation Devices Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2023 - 2029 |
| 11.6. Asia-Pacific Tumour Ablation Devices Market Dynamics Trends |
| 12. Latin America Tumour Ablation Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Tissue Contact Probe Ablators |
| 12.1.2. Epidermal and Subcutaneous Cryoablation Systems |
| 12.1.3. Tissue Spray Probe Ablators |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Breast Cancer |
| 12.2.2. Prostate Cancer |
| 12.2.3. Lung Cancer |
| 12.2.4. Liver Cancer |
| 12.2.5. Renal Cancer |
| 12.2.6. Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Hospitals |
| 12.3.2. Specialty Clinics |
| 12.3.3. Ambulatory Surgical Centers |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Tumour Ablation Devices Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2023 - 2029 |
| 12.6. Latin America Tumour Ablation Devices Market Dynamics Trends |
| 13. Middle East and Africa Tumour Ablation Devices Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 13.1. By Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Tissue Contact Probe Ablators |
| 13.1.2. Epidermal and Subcutaneous Cryoablation Systems |
| 13.1.3. Tissue Spray Probe Ablators |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Breast Cancer |
| 13.2.2. Prostate Cancer |
| 13.2.3. Lung Cancer |
| 13.2.4. Liver Cancer |
| 13.2.5. Renal Cancer |
| 13.2.6. Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Hospitals |
| 13.3.2. Specialty Clinics |
| 13.3.3. Ambulatory Surgical Centers |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Tumour Ablation Devices Market - Opportunity Analysis Index, By Product Type, Application, End User, and Country, 2023 - 2029 |
| 13.6. MEA Tumour Ablation Devices Market Dynamics Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Boston Scientific Corporation |
| 14.2.2. Cooper Surgical |
| 14.2.3. Sanarus Technologies |
| 14.2.4. Atricure, Inc. |
| 14.2.5. IceCure Medical |
| 14.2.6. CPSI Biotech |
| 14.2.7. HealthTronics, Inc. |
| 14.2.8. RA Distribution |
| 14.2.9. Brymill Cryogenic Systems |
| 14.2.10. Erbe Elektromedizin, GmbH |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Boston Scientific Corporation
- Cooper Surgical
- Sanarus Technologies
- Atricure, Inc.
- IceCure Medical
- CPSI Biotech
- HealthTronics, Inc.
- RA Distribution
- Brymill Cryogenic Systems
- Erbe Elektromedizin, GmbH